In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis

2021 ◽  
Author(s):  
Katarzyna Kowalczyk ◽  
Julio César Torres‐Elguera ◽  
Anna Jarek ◽  
Anna Konopka ◽  
Dorota Kwiatkowska ◽  
...  

2021 ◽  
Author(s):  
Charlotte Cutler ◽  
Marjaana Viljanto ◽  
Polly Taylor ◽  
Pamela Hincks ◽  
Simon Biddle ◽  
...  




2015 ◽  
Vol 7 (8) ◽  
pp. 673-683 ◽  
Author(s):  
Annelie Hansson ◽  
Heather Knych ◽  
Scott Stanley ◽  
Mario Thevis ◽  
Ulf Bondesson ◽  
...  




2012 ◽  
Vol 32 (9) ◽  
pp. 562-568 ◽  
Author(s):  
Oliver Krug ◽  
Andreas Thomas ◽  
Simon Beuck ◽  
Ina Schenk ◽  
Marc Machnik ◽  
...  


2010 ◽  
Vol 2 (11-12) ◽  
pp. 589-598 ◽  
Author(s):  
Mario Thevis ◽  
Enrico Gerace ◽  
Andreas Thomas ◽  
Simon Beuck ◽  
Hans Geyer ◽  
...  


Molecules ◽  
2019 ◽  
Vol 24 (23) ◽  
pp. 4227
Author(s):  
Shao ◽  
Zhou ◽  
Yang ◽  
Wang ◽  
Lu ◽  
...  

The pentafluorosulfane (SF5) group, as a more electronegative bioisostere than the trifluoromethyl (CF3) group, has been gaining greater attention and increasingly reported usage in medicinal chemistry. Ostarine is the selective androgen receptor modulators (SARMs) containing a CF3 group in clinical trial III. In this study, 21 ostarine derivatives for replacing the CF3 group with SF5 substituents were synthesized. Some SF5-derivatives showed androgen receptor (AR) agonistic activities in vitro. The results pointed to the potential of using this scaffold to develop new AR agonists.



Sign in / Sign up

Export Citation Format

Share Document